Sharon Gowan

5.5k total citations · 1 hit paper
36 papers, 3.3k citations indexed

About

Sharon Gowan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sharon Gowan has authored 36 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sharon Gowan's work include Advanced biosensing and bioanalysis techniques (12 papers), RNA Interference and Gene Delivery (10 papers) and DNA and Nucleic Acid Chemistry (9 papers). Sharon Gowan is often cited by papers focused on Advanced biosensing and bioanalysis techniques (12 papers), RNA Interference and Gene Delivery (10 papers) and DNA and Nucleic Acid Chemistry (9 papers). Sharon Gowan collaborates with scholars based in United Kingdom, United States and Spain. Sharon Gowan's co-authors include Lloyd R. Kèlland, Stephen Neidle, Martin A. Read, Suzanne A. Eccles, Anthony P. Reszka, Marta Mendiola, Miriam Zimmermann, David Hardisson, Lisa Patterson and Maria Vinci and has published in prestigious journals such as Cancer Research, Clinical Infectious Diseases and Biochemical Journal.

In The Last Decade

Sharon Gowan

36 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation

2012 783 citations Maria Vinci, Sharon Gowan et al. BMC Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon Gowan United Kingdom	22	2.2k	562	459	323	283	36	3.3k
Ali Bettaı̈eb France	39	2.2k 1.0×	733 1.3×	170 0.4×	434 1.3×	274 1.0×	132	4.0k
Kerri Mowen United States	25	2.5k 1.2×	864 1.5×	180 0.4×	305 0.9×	416 1.5×	33	5.3k
Ronald C. Hendrickson United States	31	3.2k 1.5×	1.9k 3.3×	553 1.2×	123 0.4×	330 1.2×	68	5.6k
Shensi Shen France	26	1.9k 0.9×	1.1k 1.9×	329 0.7×	145 0.4×	133 0.5×	52	4.2k
Annette R. Khaled United States	32	1.7k 0.8×	868 1.5×	244 0.5×	115 0.4×	81 0.3×	73	3.6k
Roman Mezencev United States	29	1.1k 0.5×	472 0.8×	474 1.0×	97 0.3×	238 0.8×	86	2.4k
Hiroyuki Tsuchiya Japan	31	1.3k 0.6×	471 0.8×	178 0.4×	210 0.7×	88 0.3×	164	3.1k
Linda K. Jolliffe United States	31	1.5k 0.7×	780 1.4×	114 0.2×	280 0.9×	282 1.0×	60	3.7k
Aaron Muth United States	25	1.1k 0.5×	288 0.5×	230 0.5×	121 0.4×	258 0.9×	55	2.6k

Countries citing papers authored by Sharon Gowan

Since Specialization

Citations

This map shows the geographic impact of Sharon Gowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Gowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Gowan more than expected).

Fields of papers citing papers by Sharon Gowan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Gowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Gowan. The network helps show where Sharon Gowan may publish in the future.

Co-authorship network of co-authors of Sharon Gowan

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Gowan. A scholar is included among the top collaborators of Sharon Gowan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Gowan. Sharon Gowan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pál, Ákos, Sharon Gowan, Yasmin J. Asad, et al.. (2022). Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay—Biological Implications. Cells. 11(20). 3286–3286. 6 indexed citations

Ferreira, Miguel Reis, Jervoise Andreyev, Kabir Mohammed, et al.. (2019). Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy. Clinical Cancer Research. 25(21). 6487–6500. 138 indexed citations

Andrejeva, Gabriela, Sharon Gowan, Gigin Lin, et al.. (2019). De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy. Autophagy. 16(6). 1044–1060. 76 indexed citations

Al-Saffar, Nada M.S., Helen Troy, L. Elizabeth Jackson, et al.. (2018). Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma. British Journal of Cancer. 119(9). 1118–1128. 14 indexed citations

Gowan, Sharon, et al.. (2014). Effects of anti-proliferative lichen metabolite, protolichesterinic acid on fatty acid synthase, cell signalling and drug response in breast cancer cells. Phytomedicine. 21(12). 1717–1724. 34 indexed citations

Renshaw, Jane, Kathryn R. Taylor, Ryan T. Bishop, et al.. (2013). Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo. Clinical Cancer Research. 19(21). 5940–5951. 110 indexed citations

Box, Carol, Marta Mendiola, Sharon Gowan, et al.. (2013). A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma. European Journal of Cancer. 49(11). 2512–2521. 11 indexed citations

Vinci, Maria, Sharon Gowan, Frances Boxall, et al.. (2012). Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biology. 10(1). 29–29. 783 indexed citations breakdown →

Bielen, Aleksandra, Lara Perryman, Gary Box, et al.. (2011). Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β. Molecular Cancer Therapeutics. 10(8). 1407–1418. 41 indexed citations

10.

Gaspar, Nathalie, Swee Y. Sharp, Suzanne A. Eccles, et al.. (2010). Mechanistic Evaluation of the Novel HSP90 Inhibitor NVP-AUY922 in Adult and Pediatric Glioblastoma. Molecular Cancer Therapeutics. 9(5). 1219–1233. 62 indexed citations

11.

Gowan, Sharon, Anthea Hardcastle, Albert Hallsworth, et al.. (2007). Application of Meso Scale Technology for the Measurement of Phosphoproteins in Human Tumor Xenografts. Assay and Drug Development Technologies. 5(3). 391–402. 36 indexed citations

12.

Reszka, Anthony P., Shozeb Haider, Bárbara Romagnoli, et al.. (2004). Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding. Bioorganic & Medicinal Chemistry Letters. 14(23). 5845–5849. 67 indexed citations

13.

Gowan, Sharon, John Harrison, Lisa Patterson, et al.. (2002). A G-Quadruplex-Interactive Potent Small-Molecule Inhibitor of Telomerase Exhibiting in Vitro and in Vivo Antitumor Activity. Molecular Pharmacology. 61(5). 1154–1162. 247 indexed citations

14.

Martin, Diana, Androulla Efstratiou, T. A. Thompson, et al.. (2002). Extension of the Lancefield Classification for Group A Streptococci by Addition of 22 New M Protein Gene Sequence Types from Clinical Isolates: emm103 to emm124. Clinical Infectious Diseases. 34(1). 28–38. 126 indexed citations

15.

Gowan, Sharon, et al.. (2001). Potent Inhibition of Telomerase by Small-Molecule Pentacyclic Acridines Capable of Interacting with G-Quadruplexes. Molecular Pharmacology. 60(5). 981–988. 6 indexed citations

16.

Caprio, Vittorio, Yaw Opoku‐Boahen, John Mann, et al.. (2000). A novel inhibitor of human telomerase derived from 10H-indolo[3,2-b]quinoline. Bioorganic & Medicinal Chemistry Letters. 10(18). 2063–2066. 97 indexed citations

17.

Read, Martin A., et al.. (1999). Molecular Modeling Studies on G-Quadruplex Complexes of Telomerase Inhibitors: Structure−Activity Relationships. Journal of Medicinal Chemistry. 42(22). 4538–4546. 126 indexed citations

18.

Gowan, Sharon, et al.. (1997). Human Thyroid Transcription Factor-1. CHEST Journal. 111(6). 88S–88S. 1 indexed citations

19.

Bingle, Colin D. & Sharon Gowan. (1996). Molecular cloning of the forkhead transcription factor HNF-3α from a human pulmonary adenocarcinoma cell line. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1307(1). 17–20. 11 indexed citations

20.

Bingle, Colin D. & Sharon Gowan. (1996). Oct-1 interacts with conserved motifs in the human thyroid transcription factor 1 gene minimal promoter. Biochemical Journal. 319(3). 669–674. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact